1. Kumari A, Agarwal Y, Singh SB, Mahajan S, Sharma V.Correlation of Lipid Profile with Inflammatory Markers among COVID-19 Positive Patients: A Retrospective Study. J Clin of Diagn Res 2022;16: BC19-BC23. https: //doi.org/10.7860/JCDR/2022/55477.16744 [
DOI:10.7860/JCDR/2022/55477.16744]
2. Feingold KR. The bidirectional link between HDL and COVID-19 Infections. J Lipid Res 2021;62: 100067. https: //doi.org/10.1016/j.jlr.2021.100067 [
DOI:10.1016/j.jlr.2021.100067] [
PMID] [
]
3. Abu-Farha M, Thanaraj TA, Qaddoumi MG, Hashem A, Abubaker J, Al-Mulla F. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target. Int J Mol Sci 2020;21: 3544. https: //doi.org/10.3390/ijms21103544 [
DOI:10.3390/ijms21103544] [
PMID] [
]
4. Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development. Front Cell Infect Microbiol 2020;10: 587269. https: //doi.org/10.3389/fcimb.2020.587269 [
DOI:10.3389/fcimb.2020.587269] [
PMID] [
]
5. Levin MG. Circulating Lipids and COVID-19: Insights From Mendelian Randomization. Arterioscler Thromb Vasc Biol 2021;41: 2811-3. https: //doi.org/10.1161/ATVBAHA.121.316940 [
DOI:10.1161/ATVBAHA.121.316940] [
PMID] [
]
6. Theken KN, Tang SY, Sengupta S, FitzGerald GA. The roles of lipids in SARS-CoV-2 viral replication and the host immune response. J Lipid Res 2021;62: 100129. https: //doi.org/10.1016/j.jlr.2021.100129 [
DOI:10.1016/j.jlr.2021.100129] [
PMID] [
]
7. WHO. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organ 2020;1-10. [
URL]
8. Feingold KR, Grunfeld C. Lipids: a key player in the battle between the host and microorganisms. J Lipid Res 2012;53: 2487-9. https: //doi.org/10.1194/jlr.E033407 [
DOI:10.1194/jlr.E033407] [
PMID] [
]
9. Heaton NS, Randall G. Multifaceted roles for lipids in viral infection. Trends Microbiol 2011;19: 368-75. https: //doi.org/10.1016/j.tim.2011.03.007 [
DOI:10.1016/j.tim.2011.03.007] [
PMID] [
]
10. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45: 1169-96. https: //doi.org/10.1194/jlr.R300019-JLR200 [
DOI:10.1194/jlr.R300019-JLR200] [
PMID]
11. Sun JT, Chen Z, Nie P, Ge H, Shen L, Yang F, et al. Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19. Front Cardiovasc Med 2020;7: 584987. https: //doi.org/10.3389/fcvm.2020.584987 [
DOI:10.3389/fcvm.2020.584987] [
PMID] [
]
12. Masana L, Correig E, Ibarretxe D, Anoro E,Arroyo J A, Jericó C, et al. Low HDL and high triglycerides predict COVID-19 severity. Sci Rep 2021;11: 1-9. https: //doi.org/10.1038/s41598-021-86747-5 [
Google Scholar]
13. Rezaei A, Neshat S, Heshmat-Ghahdarijani K. Alterations of Lipid Profile in COVID-19: A Narrative Review. Curr Probl Cardiol2022 ;47: 100907. https: //doi.org/10.1016/j.cpcardiol.2021.100907 [
DOI:10.1016/j.cpcardiol.2021.100907] [
PMID] [
]
14. Mohammedsaeed W, Alahamadey Z, Khan SM. Alteration of Lipid Profile in Covid-19 Saudi Patients At Al-Madinah Al-Munawarah. Eur J Biomed Pharm Sci 2020;7: 63-7. [
Google Scholar]
15. Saeed GA, Gaba W, Shah A, Al Helali AA, Raidullah E, Al Ali AB, et al. Correlation between Chest CT Severity Scores and the Clinical Parameters of Adult Patients with COVID-19 Pneumonia. Radiol Res Pract 2021;2021: 6697677. https: //doi.org/10.1155/2021/6697677 [
DOI:10.1155/2021/6697677] [
PMID] [
]
16. Hu X, Chen D, Wu L, He G, Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta 2020;510: 105-10. https: //doi.org/10.1016/j.aca.2020.01.026 [
DOI:10.1016/j.cca.2020.07.015] [
PMID] [
]
17. Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M,et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med 2021;26: 107-8. https: //doi.org/10.1136/bmjebm-2020-111536 [
DOI:10.1136/bmjebm-2020-111536] [
PMID] [
]